Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Russo C, Walicka M, Caponnetto P, Cibella F, Maglia M, Alamo A, Campagna D, Frittitta L, Di Mauro M, Caci G, Krysinski A, Franek E, Polosa R. Russo C, et al. Among authors: krysinski a. JAMA Netw Open. 2022 Jun 1;5(6):e2217709. doi: 10.1001/jamanetworkopen.2022.17709. JAMA Netw Open. 2022. PMID: 35727580 Free PMC article. Clinical Trial.
A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol.
Russo C, Caponnetto P, Cibella F, Maglia M, Alamo A, Campagna D, Frittitta L, Di Mauro M, Leotta C, Mondati E, Krysiński A, Franek E, Polosa R. Russo C, et al. Among authors: krysinski a. Intern Emerg Med. 2021 Oct;16(7):1823-1839. doi: 10.1007/s11739-021-02684-1. Epub 2021 Mar 18. Intern Emerg Med. 2021. PMID: 33735416 Free PMC article. Clinical Trial.
International randomised controlled trial evaluating metabolic syndrome in type 2 diabetic cigarette smokers following switching to combustion-free nicotine delivery systems: the DIASMOKE protocol.
Krysinski A, Russo C, John S, Belsey JD, Campagna D, Caponnetto P, Vudu L, Lim CW, Purrello F, Di Mauro M, Iqbal F, Fluck D, Franek E, Polosa R, Sharma P; DIASMOKE collaborators. Krysinski A, et al. BMJ Open. 2021 Apr 27;11(4):e045396. doi: 10.1136/bmjopen-2020-045396. BMJ Open. 2021. PMID: 33906842 Free PMC article. Retracted.
A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters in individuals with type 2 diabetes who smoke: the DiaSmokeFree study protocol.
Krysiński A, Russo C, Campagna D, Di Pino A, John S, Belsey J, Caponnetto P, Vudu L, Lim CW, Di Ciaula A, Veronese N, Barbagallo M, Iqbal F, Fluck D, Franek E, Polosa R, Sharma P; DiaSmokeFree investigators. Krysiński A, et al. Intern Emerg Med. 2024 Mar;19(2):321-332. doi: 10.1007/s11739-023-03467-6. Epub 2023 Nov 24. Intern Emerg Med. 2024. PMID: 37999870 Free PMC article.
Resonant metasurfaces at oblique incidence: interplay of order and disorder.
Albooyeh M, Kruk S, Menzel C, Helgert C, Kroll M, Krysinski A, Decker M, Neshev DN, Pertsch T, Etrich C, Rockstuhl C, Tretyakov SA, Simovski CR, Kivshar YS. Albooyeh M, et al. Among authors: krysinski a. Sci Rep. 2014 Mar 27;4:4484. doi: 10.1038/srep04484. Sci Rep. 2014. PMID: 24670919 Free PMC article.